Analytical Data
-
Gene name
X4S
- Application
-
Alternative Names
Allergen Der p VI DP5 Allergen: Der p 6
-
Species
Dermatophagoides pteronyssinus
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P49277
-
Expression Region
1-20aa(X4S)
-
Molecular Weight
29.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of recombinant proteins, particularly the X4S protein, has garnered significant attention in the field of molecular biology due to its potential applications in drug development and immunotherapy. X4S, a member of the glycoprotein family, plays a crucial role in various biological processes, including cell signaling and immune response modulation. The increasing prevalence of chronic diseases and infections has necessitated the exploration of novel therapeutic targets, prompting researchers to focus on understanding the structure-function relationship of X4S. Through recombinant DNA technology, scientists can produce large quantities of X4S in host cells, allowing for detailed biochemical characterization and the evaluation of its biological activities. Moreover, advances in protein engineering techniques enable the modification of X4S for enhanced stability, specificity, and efficacy in therapeutic applications. Understanding the mechanisms by which X4S interacts with cellular receptors and pathways will provide insights into its role in disease progression and treatment. Consequently, research surrounding X4S not only contributes to fundamental biological knowledge but also paves the way for innovative approaches in clinical settings, addressing pressing health challenges.
